007370 — Jin Yang Pharmaceutical Co Income Statement
0.000.00%
- KR₩60bn
- KR₩57bn
- KR₩94bn
- 89
- 88
- 12
- 73
Annual income statement for Jin Yang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 47,351 | 49,525 | 62,839 | 76,264 | 94,111 |
Cost of Revenue | |||||
Gross Profit | 24,063 | 26,282 | 33,984 | 45,651 | 57,459 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 47,824 | 45,264 | 55,876 | 64,800 | 84,816 |
Operating Profit | -473 | 4,261 | 6,964 | 11,464 | 9,295 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,070 | 6,533 | 12,132 | 14,535 | 12,583 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,647 | 5,229 | 9,538 | 12,308 | 12,659 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,647 | 5,229 | 9,538 | 12,308 | 12,659 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,647 | 5,229 | 9,622 | 12,309 | 12,660 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 165 | 468 | 842 | 894 | 1,004 |
Dividends per Share |